| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VIVO | Common Stock | Options Exercise | $647K | +44.7K | +16.84% | $14.50 | 310K | Jun 22, 2022 | Direct | |
| transaction | VIVO | Common Stock | Sale | -$1.33M | -44.7K | -14.41% | $29.72 | 265K | Jun 22, 2022 | Direct | F1, F2 |
| transaction | VIVO | Common Stock | Options Exercise | $77.6K | +5.35K | +2.02% | $14.50 | 270K | Jun 23, 2022 | Direct | |
| transaction | VIVO | Common Stock | Options Exercise | $148K | +14.6K | +5.4% | $10.10 | 285K | Jun 23, 2022 | Direct | |
| transaction | VIVO | Common Stock | Sale | -$598K | -20K | -7% | $29.98 | 265K | Jun 23, 2022 | Direct | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VIVO | Stock Options (Right to Buy) | Options Exercise | $0 | -44.7K | -89.3% | $0.00 | 5.35K | Jun 22, 2022 | Common Stock | 44.7K | $14.50 | Direct | F5, F6 |
| transaction | VIVO | Stock Options (Right to Buy) | Options Exercise | $0 | -5.35K | -100% | $0.00* | 0 | Jun 23, 2022 | Common Stock | 5.35K | $14.50 | Direct | F6, F7 |
| transaction | VIVO | Stock Options (Right to Buy) | Options Exercise | $0 | -14.6K | -9.38% | $0.00 | 141K | Jun 23, 2022 | Common Stock | 14.6K | $10.10 | Direct | F8, F9 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $29.50 to $29.94. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. |
| F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021. |
| F4 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $29.61 to $30.13. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. |
| F5 | The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021. |
| F6 | These non-qualified options were awarded under the 2012 Stock Incentive Plan upon Mr. Kenny being hired as Chief Executive Officer. The options vested in four (4) equal installments from the date of grant until fully vested on October 9, 2021. |
| F7 | The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021. |
| F8 | The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021. |
| F9 | These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date. |